Impact of public restrictive measures on hypertension during the COVID-19 pandemic: existing evidence and long-term implications
Artemios Karagiannidis(Aristotle University of Thessaloniki), Pantelis Sarafidis(Ippokrateio General Hospital of Thessaloniki), Alexandre Persu(Cliniques Universitaires Saint-Luc), Marieta Theodorakopoulou(Aristotle University of Thessaloniki), Andrzej Januszewicz(Hypertension Institute), Charles J. Ferro(Queen Elizabeth Hospital Birmingham), Alberto Ortíz(Universidad Pontificia de Salamanca), Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), María José Soler(Mayo Clinic), Reinhold Kreutz(Humboldt-Universität zu Berlin)
Cited by 16
Related Papers
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.5k
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
|European Heart Journal|2024|1.9k
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
Chronic Kidney Disease and Coronary Artery Disease
|Journal of the American College of Cardiology|2019|716